Literature DB >> 18191295

Patient acceptance of rapid HIV testing practices in an urban emergency department: assessment of the 2006 CDC recommendations for HIV screening in health care settings.

Jason S Haukoos1, Emily Hopkins, Richard L Byyny.   

Abstract

STUDY
OBJECTIVE: The Centers for Disease Control and Prevention (CDC) recently released revised recommendations for HIV testing in health care settings, calling for the performance of nontargeted opt-out HIV screening, the integration of informed consent for HIV testing into the general consent for medical care, and the uncoupling of prevention counseling and testing. It is unclear, however, whether patients will understand opt-out screening or be satisfied with integration of the consent for HIV testing into the general medical consent or the uncoupling of counseling from testing. The objective of this study is to evaluate patients' acceptance of the CDC's revised recommendations in an urban emergency department (ED).
METHODS: This was a cross-sectional survey study performed in the ED of an urban, public safety net hospital. The approximate annual ED census is 55,000 patients, and an approximate undiagnosed HIV seroprevalence ranges from 0.7% to 2.2%. A standardized survey instrument was developed and piloted and was then implemented with trained research assistants. Adult patients who were awake, alert, and agreed to participate in the study were included.
RESULTS: During the 3-month study period, 529 patients were enrolled. The median age was 38 years (interquartile range 27 to 49 years; range 18 to 87 years), 57% were men, 48% were white, 28% were Hispanic, 18% were black, and 6% represented another race or ethnicity. When patients were asked whether they would have been tested had opt-out methodology been used, 81% (95% confidence interval [CI] 77% to 84%) would have agreed to be tested. When asked whether they would have been tested had opt-in methodology been used, there was no difference (absolute difference 0%; 95% CI -5% to 4%). However, explanation of opt-out screening was required for 11% (95% CI 8% to 14%), whereas explanation of opt-in screening was required for only 2% (95% CI 1% to 4%) (absolute difference 9%; 95% CI 5% to 11%). When asked whether the patient's physician recommended an HIV test during the ED visit, 93% (95% CI 91% to 95%) would have agreed to be tested. When asked whether consent for HIV testing should be separate from consent for general emergency medical care, 50% (95% CI 46% to 54%) agreed. When asked whether counseling was necessary before performing an HIV test, 34% (95% CI 30% to 38%) agreed, and when asked whether counseling was necessary after receiving a negative HIV test result, 35% (95% CI 31% to 40%) agreed.
CONCLUSION: A large proportion of ED patients appear willing to be screened for HIV infection in accordance with the CDC's revised recommendations for HIV testing in health care settings. Similar proportions were willing to be tested when opt-out or opt-in screening strategies were used; however, a significantly greater proportion required explanation of opt-out screening.

Entities:  

Mesh:

Year:  2008        PMID: 18191295     DOI: 10.1016/j.annemergmed.2007.10.028

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  27 in total

1.  Efficacy of an emergency department-based HIV screening program in the Deep South.

Authors:  Matthew A Wheatley; Brittney Copeland; Bijal Shah; Katherine Heilpern; Carlos Del Rio; Debra Houry
Journal:  J Urban Health       Date:  2011-12       Impact factor: 3.671

2.  Missed opportunities: Undiagnosed HIV infection in patients with viral hepatitis.

Authors:  Anna Maria Geretti; Sara Madge; Marcus Posner; Geoff Dusheiko; Michael Jacobs
Journal:  BMJ       Date:  2008-06-28

3.  Prevalence of undiagnosed and suboptimally controlled diabetes by point-of-care HbA1C in unselected emergency department patients.

Authors:  Michael D Menchine; Sanjay Arora; Carlos A Camargo; Adit A Ginde
Journal:  Acad Emerg Med       Date:  2011-03-01       Impact factor: 3.451

4.  HIV Drug Therapy in the Americas 16-18 April 2015, Mexico City, Mexico.

Authors: 
Journal:  J Int AIDS Soc       Date:  2015-04-16       Impact factor: 5.396

5.  Payer status, race/ethnicity, and acceptance of free routine opt-out rapid HIV screening among emergency department patients.

Authors:  Jeffrey Sankoff; Emily Hopkins; Comilla Sasson; Alia Al-Tayyib; Brooke Bender; Jason S Haukoos
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

6.  HIV screening practices in U.S. hospitals, 2009-2010.

Authors:  Andrew C Voetsch; James D Heffelfinger; Juliet Yonek; Pragna Patel; Steven F Ethridge; Gretchen W Torres; Margaret A Lampe; Bernard M Branson
Journal:  Public Health Rep       Date:  2012 Sep-Oct       Impact factor: 2.792

7.  Diagnosing HIV infection in primary care settings: missed opportunities.

Authors:  Tammy Chin; Charles Hicks; Gregory Samsa; Mehri McKellar
Journal:  AIDS Patient Care STDS       Date:  2013-06-25       Impact factor: 5.078

8.  Informed consent for opt-in HIV testing via tablet kiosk: an assessment of patient comprehension and acceptability.

Authors:  Mitra K Lewis; Yu-Hsiang Hsieh; Charlotte A Gaydos; Stephen C Peterson; Richard E Rothman
Journal:  Int J STD AIDS       Date:  2017-03-26       Impact factor: 1.359

9.  Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium.

Authors:  Michael S Lyons; Christopher J Lindsell; Jason S Haukoos; Gregory Almond; Jeremy Brown; Yvette Calderon; Eileen Couture; Roland C Merchant; Douglas A E White; Richard E Rothman; Chris Aldridge; Gregory Almond; Gregory Andrade; Christian Arbelaez; Tom-meka Archinard; Steven I Aronin; Susan Barrera; Moses Bateganya; Joanna Bell-Merriam; Bob Bongiovanni; Kathleen Brady; Bernard Branson; Carol Brosgart; Jeremy Brown; Evan Cadoff; Yvette Calderon; Linda Chaille-Arnold; Ben Cheng; William Chiang; Brittney Copeland; Rosalyn L Cousar; Eileen Couture; Maggie Czarnogorski; Kit Delgado; Emily Erbelding; James Feldman; Osvaldo Garcia; Charlotte A Gaydos; Nancy Glick; Barbara Gripshover; Jason Haukoos; Alisa Hayes; James Heffelfinger; Laura Herrera; Amy Hilley; David Holtgrave; Brooke Hoots; Emily Hopkins; Debra Houry; Debra Howell; Yu-Hsiang Hsieh; Angela B Hutchinson; Blanca Jackson; Michael Jaker; Kerin Jones; Juliana Jung; Linda Kampe; Virginia Kan; Nancy Kass; Gabor D Kelen; Karen Kroc; Ann Kurth; Margaret A Lampe; Jason Leider; Michael Lemanski; Christopher J Lindsell; Michael Lyons; Sandra McGovern; Seth Mercer; Roland Merchant; Nancy Miertschin; Joan Miller; Patricia Mitchell; Sarah Nelson; Linda Onaga; David Paltiel; Sindy Paul; Harold Pollack; Stephen Raffanti; Liisa Randall; Richard Rothman; Akhter Sabreen; Jeffrey Sankoff; Vanessa Sasso; Nathaniel Bernard Saylor; Elissa Schechter; Barbara Schechtman; Steven Schrantz; Alicia Scribner; Judy Shahan; Daniel Skiest; Freya Spielberg; Irijah S Stennett; Patrick Sullivan; Cathalene Teahan; Susan Thompson; Gretchen Torres; Vicken Totten; Krystn Wagner; Rochelle Walensky; Michael Waxman; Andrea Weddle; Douglas White; Tom Widell; James A Wilde; Keith Wrenn; Juliet Yonek
Journal:  Acad Emerg Med       Date:  2008-12-06       Impact factor: 3.451

10.  Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial.

Authors:  Gillian D Sanders; Henry D Anaya; Steven Asch; Tuyen Hoang; Joya F Golden; Ahmed M Bayoumi; Douglas K Owens
Journal:  J Gen Intern Med       Date:  2010-03-04       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.